Probiotic supplementation during antibiotic treatment is unjustified in maintaining the gut microbiome diversity: a systematic review and meta-analysis.
Antibiotics
Diversity
Gastrointestinal microbiome
Meta-analysis
Probiotics
Journal
BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723
Informations de publication
Date de publication:
19 07 2023
19 07 2023
Historique:
received:
07
02
2023
accepted:
26
06
2023
medline:
21
7
2023
pubmed:
20
7
2023
entrez:
19
7
2023
Statut:
epublish
Résumé
Probiotics are often used to prevent antibiotic-induced low-diversity dysbiosis, however their effect is not yet sufficiently summarized in this regard. We aimed to investigate the effects of concurrent probiotic supplementation on gut microbiome composition during antibiotic therapy. We performed a systematic review and meta-analysis of randomized controlled trials reporting the differences in gut microbiome diversity between patients on antibiotic therapy with and without concomitant probiotic supplementation. The systematic search was performed in three databases (MEDLINE (via PubMed), Embase, and Cochrane Central Register of Controlled Trials (CENTRAL)) without filters on 15 October 2021. A random-effects model was used to estimate pooled mean differences (MD) with 95% confidence intervals (CI). This review was registered on PROSPERO (CRD42021282983). Of 11,769 identified articles, 15 were eligible in the systematic review and 5 in the meta-analyses. Quantitative data synthesis for Shannon (MD = 0.23, 95% CI: [(-)0.06-0.51]), Chao1 (MD = 11.59 [(-)18.42-41.60]) and observed OTUs (operational taxonomic unit) (MD = 17.15 [(-)9.43-43.73]) diversity indices revealed no significant difference between probiotic supplemented and control groups. Lacking data prevented meta-analyzing other diversity indices; however, most of the included studies reported no difference in the other reported α- and ß-diversity indices between the groups. Changes in the taxonomic composition varied across the eligible studies but tended to be similar in both groups. However, they showed a potential tendency to restore baseline levels in both groups after 3-8 weeks. This is the first meta-analysis and the most comprehensive review of the topic to date using high quality methods. The limited number of studies and low sample sizes are the main limitations of our study. Moreover, there was high variability across the studies regarding the indication of antibiotic therapy and the type, dose, and duration of antimicrobials and probiotics. Our results showed that probiotic supplementation during antibiotic therapy was not found to be influential on gut microbiome diversity indices. Defining appropriate microbiome diversity indices, their standard ranges, and their clinical relevance would be crucial.
Sections du résumé
BACKGROUND
Probiotics are often used to prevent antibiotic-induced low-diversity dysbiosis, however their effect is not yet sufficiently summarized in this regard. We aimed to investigate the effects of concurrent probiotic supplementation on gut microbiome composition during antibiotic therapy.
METHODS
We performed a systematic review and meta-analysis of randomized controlled trials reporting the differences in gut microbiome diversity between patients on antibiotic therapy with and without concomitant probiotic supplementation. The systematic search was performed in three databases (MEDLINE (via PubMed), Embase, and Cochrane Central Register of Controlled Trials (CENTRAL)) without filters on 15 October 2021. A random-effects model was used to estimate pooled mean differences (MD) with 95% confidence intervals (CI). This review was registered on PROSPERO (CRD42021282983).
RESULTS
Of 11,769 identified articles, 15 were eligible in the systematic review and 5 in the meta-analyses. Quantitative data synthesis for Shannon (MD = 0.23, 95% CI: [(-)0.06-0.51]), Chao1 (MD = 11.59 [(-)18.42-41.60]) and observed OTUs (operational taxonomic unit) (MD = 17.15 [(-)9.43-43.73]) diversity indices revealed no significant difference between probiotic supplemented and control groups. Lacking data prevented meta-analyzing other diversity indices; however, most of the included studies reported no difference in the other reported α- and ß-diversity indices between the groups. Changes in the taxonomic composition varied across the eligible studies but tended to be similar in both groups. However, they showed a potential tendency to restore baseline levels in both groups after 3-8 weeks. This is the first meta-analysis and the most comprehensive review of the topic to date using high quality methods. The limited number of studies and low sample sizes are the main limitations of our study. Moreover, there was high variability across the studies regarding the indication of antibiotic therapy and the type, dose, and duration of antimicrobials and probiotics.
CONCLUSIONS
Our results showed that probiotic supplementation during antibiotic therapy was not found to be influential on gut microbiome diversity indices. Defining appropriate microbiome diversity indices, their standard ranges, and their clinical relevance would be crucial.
Identifiants
pubmed: 37468916
doi: 10.1186/s12916-023-02961-0
pii: 10.1186/s12916-023-02961-0
pmc: PMC10355080
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
262Informations de copyright
© 2023. The Author(s).
Références
Trends Mol Med. 2016 Jun;22(6):458-478
pubmed: 27178527
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Blood. 2014 Aug 14;124(7):1174-82
pubmed: 24939656
Nat Commun. 2020 Sep 15;11(1):4635
pubmed: 32934239
J Infect. 2019 Dec;79(6):471-489
pubmed: 31629863
J Antimicrob Chemother. 2018 May 1;73(5):1121-1137
pubmed: 29370371
World J Gastroenterol. 2014 Sep 7;20(33):11878-85
pubmed: 25206295
Microb Pathog. 2017 Aug;109:156-161
pubmed: 28552806
Infect Dis Ther. 2021 Mar;10(1):317-333
pubmed: 33270205
Intensive Care Med. 2017 Jan;43(1):59-68
pubmed: 27837233
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Res Synth Methods. 2016 Mar;7(1):55-79
pubmed: 26332144
Nat Med. 2021 Nov;27(11):1885-1892
pubmed: 34789871
Chin Med J (Engl). 2020 Aug 5;133(15):1844-1855
pubmed: 32604176
Res Synth Methods. 2020 Sep;11(5):641-654
pubmed: 32562361
EBioMedicine. 2018 Sep;35:87-96
pubmed: 30145102
Int J Environ Res Public Health. 2013 Nov 25;10(12):6235-54
pubmed: 24287850
Stat Methods Med Res. 2018 Jun;27(6):1785-1805
pubmed: 27683581
World J Pediatr. 2021 Aug;17(4):385-393
pubmed: 34331676
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4554-61
pubmed: 20847294
Nutr Rev. 2012 Aug;70 Suppl 1:S2-9
pubmed: 22861804
J Med Microbiol. 2009 May;58(Pt 5):663-670
pubmed: 19369530
J Microbiol Biotechnol. 2017 Dec 28;27(12):2089-2093
pubmed: 29032640
Sci Rep. 2018 Jul 25;8(1):11192
pubmed: 30046129
Clin Microbiol Rev. 2021 Feb 24;34(2):
pubmed: 33627443
World J Gastroenterol. 2014 Nov 7;20(41):15163-76
pubmed: 25386066
Philos Trans R Soc Lond B Biol Sci. 2005 Oct 29;360(1462):1935-43
pubmed: 16214751
Int Immunopharmacol. 2005 Jun;5(6):1091-7
pubmed: 15829425
Gut Microbes. 2017 Jan 2;8(1):17-32
pubmed: 27973989
Nat Med. 2019 Jun;25(6):884-889
pubmed: 31133693
Helicobacter. 2016 Jun;21(3):165-74
pubmed: 26395781
J Clin Med. 2020 May 19;9(5):
pubmed: 32438747
Nutrients. 2020 May 19;12(5):
pubmed: 32438689
Future Microbiol. 2017 Feb;12:157-170
pubmed: 28139139
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Int J Antimicrob Agents. 2005 Jul;26(1):69-74
pubmed: 15967639
Crit Rev Food Sci Nutr. 2022;62(6):1427-1452
pubmed: 33198506
Eur J Clin Microbiol Infect Dis. 2020 Jul;39(7):1365-1372
pubmed: 32125555
Nat Med. 2021 Aug;27(8):1317-1319
pubmed: 34312557
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Front Plant Sci. 2022 Apr 19;13:839407
pubmed: 35519811
Nature. 2012 Sep 13;489(7415):220-30
pubmed: 22972295
BMC Med Res Methodol. 2014 Feb 18;14:25
pubmed: 24548571
Phys Biol. 2020 Mar 19;17(3):031001
pubmed: 31899899
mBio. 2014 May 06;5(3):e01021-14
pubmed: 24803517
ACS Infect Dis. 2020 Oct 9;6(10):2544-2559
pubmed: 32786282
Gut Microbes. 2021 Jan-Dec;13(1):1-21
pubmed: 33525961
Trends Microbiol. 2016 Jun;24(6):463-476
pubmed: 26897710
Helicobacter. 2020 Jun;25(3):e12690
pubmed: 32207209
Front Microbiol. 2018 Aug 03;9:1791
pubmed: 30123208
PLoS One. 2018 Sep 28;13(9):e0204253
pubmed: 30265691
Stat Med. 2003 Sep 15;22(17):2693-710
pubmed: 12939780
Appl Environ Microbiol. 2007 Mar;73(5):1576-85
pubmed: 17220268
Nutrients. 2020 Mar 29;12(4):
pubmed: 32235348
Curr Opin Microbiol. 2018 Aug;44:34-40
pubmed: 30036705
Child Obes. 2018 Nov/Dec;14(8):501-509
pubmed: 30183336
Biomed Res Int. 2017;2017:9351507
pubmed: 29230419
BMJ Open. 2021 Aug 12;11(8):e043054
pubmed: 34385227
NPJ Biofilms Microbiomes. 2019 Oct 11;5(1):30
pubmed: 31632686
J Gastroenterol Hepatol. 2021 Dec;36(12):3314-3321
pubmed: 34107551
Gastroenterology. 2020 Aug;159(2):697-705
pubmed: 32531291